SRNMF (Sirnaomics) Research & Development: $10.31 Mil (TTM As of Dec. 2025)


What is Sirnaomics Research & Development?

Sirnaomics SRNMF 28 Research & Development is $10.31 Mil as of Dec. 2025. GuruFocus rates SRNMF with a GF Score™ of 28/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sirnaomics's Research & Development for the six months ended in Dec. 2025 was $7.27 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $10.31 Mil.

Sirnaomics  (OTCPK:SRNMF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sirnaomics Research & Development Related Terms

Sirnaomics Research & Development Historical Data

* Premium members only.

The historical data trend for Sirnaomics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirnaomics Research & Development Chart

Sirnaomics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 40.67 67.64 54.38 20.80 10.31

Sirnaomics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.67 14.25 6.55 3.05 7.27

Sirnaomics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $10.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $10.31 Mil mean?
Sirnaomics (SRNMF) has a Research & Development of $10.31 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Sirnaomics and its competitors.
Is Sirnaomics' Research & Development too high?
Sirnaomics' current Research & Development is $10.31 Mil. Overall, Sirnaomics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Sirnaomics' Research & Development compare to VRTX and REGN?
Sirnaomics' Research & Development of $10.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sirnaomics and its competitors. Sirnaomics's current Research & Development is $10.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sirnaomics stock overvalued right now?
Sirnaomics (SRNMF) has a current Research & Development of $10.31 Mil. The current Research & Development is $10.31 Mil. Sirnaomics' overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sirnaomics (SRNMF), the current Research & Development is $10.31 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sirnaomics Business Description

Other Exchanges 02257:Hong Kong
Address No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China. All of the company's revenue is derived from the mainland of the People's Republic of China (the PRC). The pipeline includes: STP705, STP707, STP355, STP369, STP705, STP122G, STP125G, and STP144G.